Discover how network-based clustering is revolutionizing drug sensitivity prediction in cancer cell lines and advancing personalized oncology.
Exploring how cellular signaling pathways interact with epigenetic regulation to drive cancer development and the promising therapeutic approaches emerging from this research.
Explore how targeted therapies are pinpointing cancer's vulnerabilities through genetic, immune, and metabolic approaches in solid tumors.
New research reveals how cancer cells activate a hidden backup system—MTH1-independent 8-oxodGTPase activity—to evade targeted therapies.